CRVL 📈 CorVel - Overview

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2210061097

CRVL: Claims Management, Healthcare Solutions, Network Services, Patient Management

CorVel Corporation operates at the intersection of healthcare and technology, providing a suite of solutions designed to manage workers' compensation, auto, liability, and health claims. By leveraging advanced technologies such as artificial intelligence, machine learning, and natural language processing, the company enhances the management of care episodes and associated healthcare costs. This approach enables more efficient and effective claims processing, ultimately reducing costs for clients.

The company's network solutions services encompass a broad range of offerings, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, and facility claim review, among others. Additionally, CorVel provides professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services. Its Medicare solutions are also tailored to meet the specific needs of clients navigating the complexities of Medicare claims. By providing these comprehensive services, CorVel helps clients optimize their healthcare spending and improve patient outcomes.

CorVel's patient management services are designed to support the entire care continuum, from initial claims management to ongoing case management and vocational rehabilitation. The company's 24/7 nurse triage service provides patients with immediate access to medical guidance and support, while its utilization management and life care planning services help ensure that patients receive the most appropriate and cost-effective care. Furthermore, CorVel's claims processing services for self-insured payors enable clients to efficiently manage property and casualty insurance claims. By offering these services, CorVel assists employers, third-party administrators, insurance companies, and government agencies in managing medical costs and monitoring the quality of care associated with healthcare claims.

With a history dating back to 1987, CorVel Corporation is a well-established player in the healthcare services industry. Headquartered in Fort Worth, Texas, the company has developed a reputation for delivering innovative solutions that address the complex needs of its clients. As a publicly traded company listed on the NASDAQ exchange under the ticker symbol CRVL, CorVel is committed to transparency and accountability in its operations. With a focus on leveraging technology to drive efficiency and improve patient outcomes, CorVel is poised to continue playing a key role in the evolving healthcare landscape.

Additional Sources for CRVL Stock

CRVL Stock Overview

Market Cap in USD 6,258m
Sector Financial Services
Industry Insurance Brokers
GiC Sub-Industry Health Care Services
IPO / Inception 1991-06-28

CRVL Stock Ratings

Growth 5y 96.4%
Fundamental 68.8%
Dividend -
Rel. Strength Industry 754
Analysts -
Fair Price Momentum 412.45 USD
Fair Price DCF 110.04 USD

CRVL Dividends

No Dividends Paid

CRVL Growth Ratios

Growth Correlation 3m 62.7%
Growth Correlation 12m 88.4%
Growth Correlation 5y 93.8%
CAGR 5y 32.29%
CAGR/Mean DD 5y 2.60
Sharpe Ratio 12m 1.05
Alpha 16.06
Beta 0.84
Volatility 35.07%
Current Volume 165k
Average Volume 20d 51.7k
What is the price of CRVL stocks?
As of December 22, 2024, the stock is trading at USD 345.72 with a total of 165,030 shares traded.
Over the past week, the price has changed by -1.78%, over one month by -2.68%, over three months by +8.96% and over the past year by +43.93%.
Is CorVel a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, CorVel (NASDAQ:CRVL) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 68.75 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CRVL as of December 2024 is 412.45. This means that CRVL is currently undervalued and has a potential upside of +19.3% (Margin of Safety).
Is CRVL a buy, sell or hold?
CorVel has no consensus analysts rating.
What are the forecast for CRVL stock price target?
According to ValueRays Forecast Model, CRVL CorVel will be worth about 456.2 in December 2025. The stock is currently trading at 345.72. This means that the stock has a potential upside of +31.96%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 456.2 32%